NCT00749580 A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen Status COMPLETED Phase NA
NCT00747539 Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy Status COMPLETED Phase N/A
NCT00745823 A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071) Status TERMINATED Phase PHASE3
NCT00744887 TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT00744770 TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State. Status COMPLETED Phase PHASE1
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects Status TERMINATED Phase PHASE1
NCT00742326 Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections Status TERMINATED Phase PHASE4
NCT00740389 TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects. Status COMPLETED Phase PHASE1
NCT00739622 TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women. Status COMPLETED Phase PHASE1
NCT00738569 Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen Status COMPLETED Phase NA
NCT00737724 Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment Status TERMINATED Phase NA
NCT00736905 TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function. Status COMPLETED Phase PHASE1
NCT00686829 Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100) Status COMPLETED Phase PHASE2
NCT00668395 Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics Status COMPLETED Phase NA
NCT00650832 TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV. Status COMPLETED Phase PHASE2